Webinar 2011

Nutrigenomics and Health / Personalised Healthcare   
Wednesday, November 16, 2011  16:00 – 17.30 CET

" Nutrigenomics and Health / Personalised Healthcare” a free on-line Webinar taking place on 16 November 2011 16.00  Central European Time, 10.00  Eastern US Time, 15.00  UK Time

Registration is open please click

90 minutes Conference Agenda

Introduction- Partick Terry, Co-founder, Board Member EPEMED

Speakers:

• Prof. James Kaput, Nestlé Health Science Program Director, ClinicalTranslation Nestlé Institute Health Sciences, slideshow
• Prof. Christian Bréchot, VP Medical and Scientific affairs at Intitut Mérieux, Nutrigenetic Scientific Context,  slideshow
• Dr. Robert Jones, Scientia Advisor Foods Division, The Business of food as Medicine Principle,  slideshow

Q&A session 20 min

Moderated by Patrick Terry, board member EPEMED

Building the European Personalised Medicine Market
Wednesday, May 25, 2011 Wednesday, May 25, 2011 16:00 – 17.30 PM CET

" Building the European Personalised Medicine Market” a Webinar taking place on 25 May 2011 16.00 hr Central European Time, 10.00 AM Eastern US Time, 3.00 PM UK Time

Speakers:

• Dr. Iain Miller, bioMerieux: "Market Access Challenges in EU for High Medical Value Diagnostics Tests"
• Nick Crabb, Associate Director, Diagnostics Assessment Program, NICE: "NICE Assessment of Companion Test Products"
• Loic Kubitzka, PWC : "The opportunities and challenges of European market entry for emerging diagnostics companies"

Moderated by Dr Iain Miller, board member EPEMED

Iain Miller leads the Cambridge-based Personalized Medicine team at bioMerieux, which he joined in 2007. bioMerieux is a global In Vitro Diagnostics market leader with $1.7B in 2010 revenues. Prior to joining bioMerieux, he has held senior business development positions at US Genomics (now PathoGenetix), personalized medicine pioneer Variagenics, Candela Corporation, and Boston Consulting Group life science venture ActiveCyte. In the mid-1990s, he also managed technology partnering for Massachusetts General Hospital, and has founded two medical device ventures. Iain holds a Ph.D. in Biomedical Engineering from the University of Strathclyde, an MBA from Edinburgh Business School and a Bachelors degree in Physics from the University of Glasgow. Slideshow

Loïc Kubitza, Director - Corporate Finance, PricewaterhouseCoopers

Loïc Kubitza is the director responsible for deal advisory services to the life sciences sector at PwC in Luxembourg. He has focused on deal and strategy advisory work in the pharmaceuticals and life sciences sector since 1995 at PwC in London.  Loïc moved to Luxembourg in November 2008 following the country’s increasing diversification into life sciences. At PwC in Luxembourg, he has worked with companies in the diagnostics and pharmaceutical sectors including fund raising, licensing and strategy advisory mandates. He was the main co-author of the PwC study Diagnostics 2009: Moving towards personalised medicine. Personalised medicine became an important focus area for PwC in Luxembourg as the government announced plans to invest €140 million into three research projects involving leading US based scientists. Loïc has an MSc in Molecular Medicine (Imperial College), an MSc in Economics (Université Catholique de Louvain) and is a Chartered Accountant (ICAEW). Slideshow

Dr Nick Crabb, Associate Director – Diagnostics Assessment Programme, NICE

Nick joined NICE in January 2010 following a 20 year career in analytical science, process technology and general management in the chemical, pharmaceutical and contract laboratory industries. At NICE, Nick is responsible for the establishment and management of the new Diagnostics Assessment Programme.Slideshow